U.S. Food and Drug Administration (FDA) open to pooling data from ongoing Phase I/II studies of LX2006 with pivotal data to support a Biologics License Application (BLA) for Accelerated Approval ...
The IND is part of a pattern of progress on multiple fronts. Arcadia has raised $9.25M from investors including Sam Altman, Fred Ehrsam, and Dylan Field. The company has also secured a patent for ...
Illinois election officials late Tuesday told President Donald Trump’s Justice Department the state would not comply with the federal agency’s demand for sensitive data on the state’s roughly 8.3 ...
Arizona Secretary of State Adrian Fontes says he has refused demands from the U.S. Department of Justice to hand over voter registration information and provide his office’s voter list maintenance ...
NEW YORK – AliveDx said Tuesday that it has registered its multiplex immunoassay analyzer for autoimmune disease and allergy testing with the US Food and Drug Administration as a Class II device that ...
HUNTSVILLE, AL, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, today ...
The U.S. Food and Drug Administration reports it is launching a systematic review process for “food chemicals,” beginning with certain preservatives and whitening agents. In May, the agency said it ...
Sarepta Therapeutics (NASDAQ: SRPT) said Friday that the deaths of two patients taking its marketed gene therapy Elevidys® (delandistrogene moxeparvovec-rokl), posted on a public FDA database and ...
TAMPA, Fla., July 11, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group Inc. (OTC: FAGI) and its fifty one percent owned subsidiary, Aquaox Pure Solutions, LLC, announce two pivotal regulatory achievements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback